Changes in plasma concentrations of edoxaban and coagulation biomarkers according to thromboembolic risk and atrial fibrillation type in patients undergoing catheter ablation: Subanalysis of KYU‐RABLE

BACKGROUND: Catheter ablation (CA) for atrial fibrillation (AF) can be associated with a risk of thromboembolism and bleeding. We recently demonstrated that uninterrupted edoxaban with one dose delayed on the CA procedural day is associated with a low risk of periprocedural complications. Previous r...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinohara, Tetsuji, Takahashi, Naohiko, Mukai, Yasushi, Kimura, Tetsuya, Yamaguchi, Keita, Takita, Atsushi, Origasa, Hideki, Okumura, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896453/
https://www.ncbi.nlm.nih.gov/pubmed/33664888
http://dx.doi.org/10.1002/joa3.12490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896453/
https://www.ncbi.nlm.nih.gov/pubmed/33664888
http://dx.doi.org/10.1002/joa3.12490

Ejemplares similares